C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)

SHE:000950 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Income	432.21	386.72	282.99	624.63	952.28	1,005
Depreciation & Amortization	460.89	460.89	465.72	396.81	403.9	312.62
Other Amortization	73.86	73.86	76.8	48.52	33.17	37.51
Loss (Gain) From Sale of Assets	-4.63	-4.63	-10.53	-0.79	-10.05	-3.52
Asset Writedown & Restructuring Costs	31.69	31.69	40.21	20.49	27.93	10.67
Loss (Gain) From Sale of Investments	-412.41	-412.41	-409.33	-317.71	-305.8	-429.57
Provision & Write-off of Bad Debts	662.2	662.2	531.72	388.33	124.48	282.22
Other Operating Activities	-89.02	1,108	1,299	1,505	1,336	1,053
Change in Accounts Receivable	-2,800	-2,800	-1,663	-5,316	-3,878	-3,989
Change in Inventory	-149.15	-149.15	-1,432	-752.22	-1,824	-185.46
Change in Accounts Payable	1,673	1,673	728.6	4,007	3,401	2,183
Operating Cash Flow	-396.97	754.67	-186.74	508.53	285.83	250.16
Operating Cash Flow Growth	-	-	-	77.92%	14.26%	-60.42%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Capital Expenditures	-319.03	-299.54	-250.53	-244.41	-268.07	-489.55
Sale of Property, Plant & Equipment	1.07	1.01	1.4	0.83	6.59	11.65
Cash Acquisitions	-3.22	-25.2	-109.33	-187.75	-226.86	-650.59
Divestitures	-	0.4	-	-28.9	81.85	33.3
Investment in Securities	339.42	339.42	41.04	68.49	168.16	-39.84
Other Investing Activities	136.61	119.04	95.9	24.94	47.09	165.52
Investing Cash Flow	183.48	163.75	-182.46	-358.38	-191.24	-969.51

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Long-Term Debt Issued	-	24,919	24,230	25,555	24,481	28,019
Long-Term Debt Repaid	-	-24,422	-23,652	-26,513	-21,746	-24,862
Net Debt Issued (Repaid)	2,838	497.3	578.14	-958.02	2,735	3,157
Issuance of Common Stock	-	-	-	-	-	41.9
Common Dividends Paid	-853.62	-873.57	-1,120	-1,299	-928.81	-1,227
Other Financing Activities	-604.59	-578.16	590.28	2,510	-626.11	-429.17
Financing Cash Flow	1,379	-954.43	48.33	252.49	1,180	1,542

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Foreign Exchange Rate Adjustments	-	-	-	-	-	-0.12
Net Cash Flow	1,166	-36.02	-320.87	402.64	1,274	822.74

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Free Cash Flow	-716	455.13	-437.27	264.13	17.76	-239.38
Free Cash Flow Growth	-	-	-	1386.93%	-	-
Free Cash Flow Margin	-0.87%	0.55%	-0.54%	0.34%	0.03%	-0.38%
Free Cash Flow Per Share	-0.41	0.26	-0.25	0.15	0.01	-0.14
Levered Free Cash Flow	-3,152	-1,301	-1,389	1,225	-2,481	-3,830
Unlevered Free Cash Flow	-2,693	-827.23	-677.52	2,063	-1,778	-3,139

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash Income Tax Paid	1,707	1,550	1,438	1,755	1,384	1,351
Change in Working Capital	-1,552	-1,552	-2,463	-2,157	-2,276	-2,018

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error